KNW
GDRX icon

Kesler Norman & Wride’s GoodRx Holdings GDRX Stock Holding History

Kesler Norman & Wride’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-60,535
Closed -$420K – 229
2024
Q3 		$420K Buy
+60,535
New +$475K 0.08% 185

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RRCP
Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Kesler Norman & Wride's GDRX Position: Q4 2024 in Review

Kesler Norman & Wride sold out of GoodRx Holdings (GDRX) in Q4 2024, closing a stake of 60,535 shares — an estimated $420K sold.

Kesler Norman & Wride first reported a position in GDRX in Q3 2024 and held it in 1 quarter. The position peaked at $420K in Q3 2024. 170 funds tracked by Wall St. Rank hold GDRX as of Q4 2024.

  • Kesler Norman & Wride reported no remaining GoodRx Holdings position as of Q4 2024 after selling out during the quarter.
  • Kesler Norman & Wride sold 60,535 GoodRx Holdings shares in Q4 2024, an estimated $420K.
  • Kesler Norman & Wride first reported a position in GoodRx Holdings in Q3 2024 and held it in 1 quarter.
  • Kesler Norman & Wride's GoodRx Holdings position peaked at $420K in Q3 2024.
  • 170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2024.

Based on Kesler Norman & Wride's 13F filing for Q4 2024, filed 12 Feb 2025.